{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:17:40Z","timestamp":1791811060511,"version":"4.3.4"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC0907004"],"award-info":[{"award-number":["2017YFC0907004"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Preserved ratio impaired spirometry (PRISm), characterized by the decreased forced expiratory volume in 1 s (FEV\n                    <jats:sub>1<\/jats:sub>\n                    ) and forced vital capacity (FVC) with a preserved FEV\n                    <jats:sub>1<\/jats:sub>\n                    \/FVC ratio, is highly prevalent and heterogeneous. We aimed to identify the subtypes of PRISm and examine their differences in clinical characteristics, long-term mortality risks, and longitudinal transition trajectories.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    A total of 6,616 eligible subjects were included from the English longitudinal study of aging. Two subtypes of the PRISm were identified as mild PRISm (either of FEV\n                    <jats:sub>1<\/jats:sub>\n                    and FVC &amp;lt;80% predicted value, FEV\n                    <jats:sub>1<\/jats:sub>\n                    \/FVC \u22650.7) and severe PRISm (both FEV\n                    <jats:sub>1<\/jats:sub>\n                    and FVC &amp;lt;80% predicted values, FEV\n                    <jats:sub>1<\/jats:sub>\n                    \/FVC \u22650.7). Normal spirometry was defined as both FEV\n                    <jats:sub>1<\/jats:sub>\n                    and FVC \u226580% predicted values and FEV\n                    <jats:sub>1<\/jats:sub>\n                    \/FVC \u22650.7. Hazard ratios (HRs) and 95% CIs were calculated by the multiple Cox regression models. Longitudinal transition trajectories were described with repeated spirometry data.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    At baseline, severe PRISm had increased respiratory symptoms, including higher percentages of phlegm, wheezing, dyspnea, chronic bronchitis, and emphysema than mild PRISm. After an average of 7.7 years of follow-up, severe PRISm significantly increased the risks of all-cause mortality (HR=1.91, 95%CI = 1.58\u20132.31), respiratory mortality (HR = 6.02, 95%CI = 2.83\u201312.84), and CVD mortality (HR = 2.11, 95%CI = 1.42\u20133.13) compared with the normal spirometry, but no significantly increased risks were found for mild PRISm. In the two longitudinal transitions, mild PRISm tended to transition toward normal spirometry (40.2 and 54.7%), but severe PRISm tended to maintain the status (42.4 and 30.4%) or transition toward Global Initiative for Chronic Obstructive Lung Disease (GOLD)2\u20134 (28.3 and 33.9%).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Two subtypes of PRISm were identified. Severe PRISm had increased respiratory symptoms, higher mortality risks, and a higher probability of progressing to GOLD2\u20134 than mild PRISm. These findings provided new evidence for the stratified management of PRISm.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2021.755855","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T01:31:22Z","timestamp":1636594282000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":58,"title":["Different Risks of Mortality and Longitudinal Transition Trajectories in New Potential Subtypes of the Preserved Ratio Impaired Spirometry: Evidence From the English Longitudinal Study of Aging"],"prefix":"10.3389","volume":"8","author":[{"given":"Di","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongxue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejing","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/thx.2009.126052","article-title":"Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study","volume":"65","author":"Guerra","year":"2010","journal-title":"Thorax."},{"key":"B2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.rmed.2019.04.002","article-title":"All-cause and cause-specific mortality from restrictive and obstructive spirometric patterns in Chinese adults with and without dyspnea: Guangzhou Biobank Cohort Study","volume":"151","author":"Pan","year":"2019","journal-title":"Respir Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1164\/rccm.201101-0021OC","article-title":"Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study","volume":"184","author":"Wan","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1378\/chest.08-1235","article-title":"Conditions associated with an abnormal nonspecific pattern of pulmonary function tests","volume":"135","author":"Hyatt","year":"2009","journal-title":"Chest."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1901217","DOI":"10.1183\/13993003.congress-2019.PA4421","article-title":"Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study","volume":"55","author":"Wijnant","year":"2020","journal-title":"Eur Respir J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12931-014-0089-y","article-title":"Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene","volume":"15","author":"Wan","year":"2014","journal-title":"Respir Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1378\/chest.15-1045","article-title":"The vital capacity is vital: epidemiology and clinical significance of the restrictive spirometry pattern","volume":"149","author":"Godfrey","year":"2016","journal-title":"Chest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.5588\/ijtld.12.0054","article-title":"Restricted spirometry in the Burden of Lung Disease Study","volume":"16","author":"Mannino","year":"2012","journal-title":"Int J Tuberc Lung Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12931-018-0896-7","article-title":"Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study","volume":"19","author":"Park","year":"2018","journal-title":"Respir Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ijcard.2017.04.049","article-title":"Impact of restrictive lung disorder on cardiovascular mortality in a general population: The Yamagata (Takahata) study","volume":"241","author":"Honda","year":"2017","journal-title":"Int J Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/1479972315588004","article-title":"Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study","volume":"12","author":"Nonato","year":"2015","journal-title":"Chron Respir Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1164\/rccm.201710-2108OC","article-title":"Jr","volume":"197","author":"Kalhan","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2796.2003.01211.x","article-title":"Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination","volume":"254","author":"Mannino","year":"2003","journal-title":"J Intern Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1513\/AnnalsATS.201803-184OC","article-title":"Restrictive spirometry pattern, cardiac structure and function, and incident heart failure in African Americans. The Jackson Heart Study","volume":"15","author":"Jankowich","year":"2018","journal-title":"Ann Am Thorac Soc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/thx.2007.088112","article-title":"Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort","volume":"63","author":"Johnston","year":"2008","journal-title":"Thorax."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1164\/rccm.201804-0663OC","article-title":"Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study","volume":"198","author":"Wan","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1164\/rccm.200807-1195OC","article-title":"Lung function impairment and metabolic syndrome: the critical role of abdominal obesity","volume":"179","author":"Leone","year":"2009","journal-title":"Am J Respir Crit Care Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.rmed.2016.10.005","article-title":"Restrictive spirometric pattern in the general adult population: Methods of defining the condition and consequences on prevalence","volume":"120","author":"Backman","year":"2016","journal-title":"Respir Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1016\/S2214-109X(19)30070-1","article-title":"Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV(1) (PURE): an international, community-based cohort study","volume":"7","author":"Duong","year":"2019","journal-title":"Lancet Glob Health."},{"key":"B20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/bmj.313.7059.711","article-title":"BMJ","volume":"313","year":"1996"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/ije\/dys168","article-title":"Cohort profile: the English longitudinal study of ageing","volume":"42","author":"Steptoe","year":"2013","journal-title":"Int J Epidemiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1586\/17476348.2014.919226","article-title":"Changes in lung function in older people from the English Longitudinal Study of Ageing","volume":"8","author":"Yohannes","year":"2014","journal-title":"Expert Rev Respir Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","article-title":"American thoracic society","volume":"152","year":"1995","journal-title":"Am J Respir Crit."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1900164","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019","volume":"53","author":"Singh","year":"2019","journal-title":"Eur Respir J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1378\/chest.93.3.580","article-title":"Evaluation of clinical methods for rating dyspnea","volume":"93","author":"Mahler","year":"1988","journal-title":"Chest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1164\/rccm.201011-1928OC","article-title":"Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study","volume":"184","author":"Foreman","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.chest.2019.11.039","article-title":"Machine learning characterization of COPD subtypes: insights from the COPDGene study","volume":"157","author":"Castaldi","year":"2020","journal-title":"Chest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.15326\/jcopdf.6.5.2019.0149","article-title":"COPDGene(\u00ae) 2019: redefining the diagnosis of chronic obstructive pulmonary disease","volume":"6","author":"Lowe","year":"2019","journal-title":"Chronic Obstr Pulm Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/aje\/kwy087","article-title":"Identification of chronic obstructive pulmonary disease axes that predict all-cause mortality: The COPDGene study","volume":"187","author":"Kinney","year":"2018","journal-title":"Am J Epidemiol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.755855\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T01:31:26Z","timestamp":1636594286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.755855\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":30,"alternative-id":["10.3389\/fmed.2021.755855"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.755855","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"article-number":"755855"}}